Rani Therapeutics (RANI) News
NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RANI news summary
We found 3 recent headlines mentioning Rani Therapeutics (RANI): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Nasdaq. RANI is making an outsized move today, down 11.97% at $0.5111, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Rani Therapeutics Holdings, Inc. Reports Third Quarter 2026 Financial Results and FDA Emerging Technology Program Acceptance", was published by Nasdaq on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Rani Therapeutics headlines
- Rani Therapeutics Holdings, Inc. Reports Third Quarter 2026 Financial Results and FDA Emerging Technology Program AcceptanceRani Therapeutics Holdings, Inc. reported its financial results for the third quarter ended September 30, 2026, and provided a corporate update. The company reported cash, cash equivalents and…Nasdaq
- Rani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update~ Accepted into the U.S. FDA’s Emerging Technology Program (ETP), enabling early FDA engagement to support development of the RaniPill ® platform technology ~GlobeNewswire
- Rani Therapeutics to Participate in the Chardan Healthcare ConferenceSAN JOSE, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced…GlobeNewswire